VA-008 ACAM2000® Vaccination of Plasma Donors for the Production of VIGIV

Clinical trial NCT02443623 · COMPLETED

Trial details

NCT number: NCT02443623
Sponsor: Emergent BioSolutions
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Smallpox Vaccine Adverse Reaction

Start date: 2015-09-01
Primary completion: 2021-07-01
Enrollment: 3032

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.